New site selected for Data Harmonization Working Group
We are pleased to announce that Drs. Sean Hennessy and Allison Willis from the University of Pennsylvania will represent the 5th site for the Data
When it’s better to stop or decrease health care services and interventions: researchers bring validity and transparency to deintensification recommendations in primary care.
Kerr EA, et al. Identifying recommendations for stopping or scaling back unnecessary routine services in primary care. JAMA Intern Med. 2020;180(11):1500-1508. doi:10.1001/jamainternmed.2020.4001 A recent study
2020-2021 Network Grantees Selected
We are pleased to announce our 2020-2021 cohort of network grantees. Six projects, including 2 grant planning and 4 pilots are underway.
Which Outcome Measures are Most Commonly Used in Deprescribing Interventions?
Aubert C, et al. Outcome Measures for Interventions to Reduce Inappropriate Chronic Drugs: A Narrative Review. J Am Geriatr Soc. 2020; doi: 10.1111/jgs.16697 A new
The OPTIMISE Randomized Clinical Trial: Deprescribing Antihypertensive Medications in Adults Aged 80 and Older and its Effect on Blood Pressure
Sheppard J, et al. Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients with Hypertension Aged 80 Years and
Junior Investigators Selected for Intensive in Deprescribing Research!
We are very pleased to announce our 2020-2021 cohort of Junior Investigator Intensive Awardees. The Junior Investigator Intensive program provides dedicated supports and research learning
Two new AD/ADRD-related RFAs from the IMPACT Collaboratory
The IMPACT Collaboratory released two new Requests for Applications (RFAs) for conducting pragmatic trials in persons with AD/ADRD on April 20: Request for Applications for
COVID-19 response in post-acute and long-term care: Task force develops new guide to optimize medications.
A task force convened by the Peter Lamy Center on Drug Therapy and Aging at the University of Maryland School of Pharmacy with assistance from
A new review article says it’s time to refine current adverse drug event adjudication methods to fit deprescribing studies.
Ross S, et al. Adverse Drug Events in Older Adults: Review of Adjudication Methods in Deprescribing Studies. J Am Geriatr Soc. 2020; doi: 10.1111/jgs.16382 A
Medication Fog Can Mimic or Worsen Dementia in the Elderly
“Potentially” is the key word — the drugs on the list don’t always pose a problem, and no one should stop using any medicine without first checking with a doctor because that could do serious …
USDeN Annual Meeting: Submit an Abstract
We strongly encourage and invite you to present at the USDeN annual meeting poster session; this may be a repeat or encore poster from AGS
Eliminating Medication Overload: A National Action Plan from the Lown Institute
Medication overload is an epidemic among older Americans. Every day, 750 Americans age 65 and over are hospitalized for a side effect caused by one
